Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung cancer patients who respond well to chemotherapy.
Jul 31, 2014
4 min
Video
The doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation.
Jul 27, 2014
5 min
Video
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
Jul 22, 2014
2 min
Video
The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results.
Jul 17, 2014
7 min
Video
The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.
Jul 13, 2014
7 min
Video
"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).
Jul 8, 2014
3 min
Video
Lung cancer patients with high MET amplification appear to do well on Xalcori (crizotinib), a drug that is approved for ALK positive patients.
Jul 3, 2014
7 min
Video
Lung cancer patients with the EGFR mutation who had progressed on other drugs did well on a new drug in clinical trial, though one particular side effect concerns some.
Jun 29, 2014
4 min
Video
Fibroblast growth factor receptor (FGFR) mutations may play a role in the growth of squamous cell lung cancer. Dr. Jonathan Riess talks about what they are learning in this area.
Jun 25, 2014
2 min
Video
EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial.
Jun 24, 2014
11 min
Video
Load more